ICD-10-CM Billable Code

C94.6

Myelodysplastic disease, not elsewhere classified

Clinical Classification Guidelines

Inclusion Terms

  • Myelodysplastic/myeloproliferative neoplasm, unclassifiable
  • Myeloproliferative disease, not elsewhere classified

Medical Intelligence & Overview

Myelodysplastic disease, classified under ICD-10 code C94.6, is a group of disorders caused by ineffective production of blood cells in the bone marrow. This condition results in abnormal blood cell development, leading to issues like anemia, infections, or bleeding problems. Often referred to as myelodysplastic/myeloproliferative neoplasms unclassifiable, it falls in a complex category of blood disorders that require careful medical evaluation. This guide aims to explain what this diagnosis means, its possible causes, common symptoms, and general concepts around diagnosis and treatment options.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting blood cell production Previous exposure to chemotherapy or radiation therapy Certain inherited blood disorders Environmental exposures to certain chemicals or toxins Idiopathic, meaning no clear cause can be identified in some cases

Key Symptoms: Fatigue and weakness due to anemia Increased susceptibility to infections Unusual bruising or bleeding problems Frequent or severe nosebleeds Shortness of breath Pale skin Unintentional weight loss or fever

Diagnostic & Treatment

Diagnosis Path: To diagnose myelodysplastic disease, healthcare providers typically perform a series of tests that include blood tests (such as a complete blood count), bone marrow biopsy, and sometimes genetic testing. These procedures help identify abnormalities in blood cell counts and morphology, as well as cellular and genetic features that distinguish this condition from other blood disorders. Since this disease can resemble other conditions, thorough testing is essential to establish an accurate diagnosis.

Treatment Protocols: Treatment strategies vary based on the severity of the disease, patient health, and specific blood cell problems. Common approaches include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C94.6 a billable ICD-10 code?
Yes, C94.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C94.6?
Clinical documentation must specify the nature of Myelodysplastic disease, not elsewhere classified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

myelodysplastic